new glp 1 agonist novo nordisk GLP-1s for Alzheimer's: announces trial conclusion Novo Nordisk expands patient access

Retrieved August 21, 2025, from Bozick, R., Donofry, S

We have found a significant and clinically meaningful reduction in ICP in the treatment arm as compared to the placebo arm both acutely and after 12 weeks of dosing

Sodium-glucose cotransport protein 2 inhibitors in patients with type 2 diabetes and acute kidney disease

Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis

Despite this, the ability of GLP-1 agonists to offer multiple therapeutic effects beyond their primary uses is drawing considerable interest from the medical community

This can be challenging if you cannot get enough food in your stomach to handle the vitamin, so I have been taking them when I am able to eat enough and, honestly, when I remember